Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Expert Opinion on Pharmacotherapy|June 4, 2014
In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cellsAlaaeldin Shablak, David E Gilham, Robert E Hawkins, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 25, 2009
Development of a flow cytometric co-immunoprecipitation technique for the study of multiple protein-protein interactions and its application to T-cell receptor analysisJohn S Bridgeman, Morgan Blaylock, Robert E Hawkins, et al.Cancer Immunology, Immunotherapy : CII|April 25, 2012
Targeted immunotherapy of cancer with CAR T cells: achievements and challengesGrazyna Lipowska-Bhalla, David E Gilham, Robert E Hawkins, et al.Trends in Molecular Medicine|May 23, 2012
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foeDavid E Gilham, Reno Debets, Martin Pule, et al.Human Gene Therapy Methods|September 14, 2013
Isolation of tumor antigen-specific single-chain variable fragments using a chimeric antigen receptor bicistronic retroviral vector in a Mammalian screening protocolGrazyna Lipowska-Bhalla, David E Gilham, Robert E Hawkins, et al.The Journal of Gene Medicine|December 25, 2009
Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectorsDavid E Gilham, Michael Lie-A-Ling, Naomi Taylor, et al.Journal of Visualized Experiments : Jove|November 6, 2018
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T CellsGray Kueberuwa, Weiming Zheng, Milena Kalaitsidou, et al.Immunology|April 25, 2006
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4Irina Redchenko, Richard Harrop, Matthew G Ryan, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2007
CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cellsEyad Elkord, Deborah J Burt, Jan W Drijfhout, et al.Oncology|September 18, 2014
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinomaCora N Sternberg, Ian D Davis, Keith C Deen, et al.Pageof 8